Notch2 deficiency reduces the anti-tumor efficacy of dendritic cells (DCs), impacting T cell-mediated anti-tumor responses such as differentiation, migration, and antigen cross-presentation to CD8 + T cells [159]. The gene discussed is NOTCH2; the disease is neoplasm.